respiratory side effects
decreased oxygen saturation
hypoxia
respiratory depression
hypercapnia
dyspnea
postmarketing experience
severe respiratory depression
involving apnea
respiratory arrest
cardiac arrest
been reported following administration
labeled doses of morphine sulfate
extended-release liposome injection
percent of the patients
morphine
clinical trials
required treatment with narcotic antagonists for respiratory depression
percent of events of respiratory depression
first hours after dosing with morphine
respiratory depression
patients after more than hours
cardiovascular
side effects
hypotension
tachycardia
hypertension
bradycardia
genitourinary side effects
urinary retention
bladder spasm
oliguria
gastrointestinal side effects
vomiting
constipation
nausea
flatulence
paralytic ileus
dyspepsia
abdominal distention
dermatologic side effects
pruritus
hypoesthesia
sweating
general
side effects
pyrexia
headache
dizziness
insomnia
somnolence
anxiety
pain
hematologic side effects
anemia
hypokalemia
hematocrit
musculoskeletal side effects
rigors
nervous system
side effects
paresthesia
postmarketing experience
central nervous system depression
including
obtunded feeling
non-arousable condition
unresponsiveness
confusion
lethargy
been reported following
been reported following epidural administration of morphine sulfate
extended-release liposome injection
cases with central nervous system depression
following epidural administration of morphine sulfate
extended-release liposome injection
concomitant administration of different narcotics
hypnotic/sedative medications in the postoperative period
oncologic side effects
increase in dna fragmentation
human lymphoma cell line
morphine
increase in the frequency of micronuclei in bone marrow cells
immature red blood cells in the mouse micronucleus test
chromosomal aberrations in murine lymphocytes
spermatids
clastogenic effects
morphine in mice
increases in glucocorticoid levels
morphine in that species